All NICE products on medicines management. Includes any guidance, advice and quality standards.
We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Published guidance on this topic (14)
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
Published advice on this topic (3)
Set out priority areas for quality improvement in health and social care.
Published quality standards on this topic (8)
Review the evidence across broad health and social care topics.
Review the best available evidence for selected medicines.
Review the evidence and likely costs of medical devices and technologies.
Guidance, quality standards and advice being developed.
Guidance and quality standards awaiting development.
Two new antimicrobial drugs - cefiderocol and ceftazidime–avibactam - are close to becoming the first to be made available as part of the UK’s innovative subscription-style payment model after NICE today (Tuesday, 12 April 2022) published draft guidance estimating their value to the NHS.
Examples of how our guidance and standards have been put into practice in the NHS, local authorities, voluntary sector and a range of other organisations.
Showing 3 of 50 shared learning examples for this topic: